23 June 2009
Effect of noise conditioning on cisplatin-induced ototoxicity: a pilot study
Sathiyaseelan TheneshkumarABDEF, Guiscardo LoritoBF, Pietro GiordanoCD, Joseph PetruccelliCD, Alessandro MartiniAG, Stavros HatzopoulosACDEMed Sci Monit 2009; 15(7): BR173-177 :: ID: 869701
Abstract
Background
Cisplatin is a platinum-based chemotherapeutic agent that is highly effective in the treatment of cancer. Ototoxicity is an important dose-limiting adverse effect of cisplatin, in addition to nephrotoxicity. Studies have shown that cisplatin-induced ototoxicity is mainly a result of generated reactive oxygen species. Sulfur-containing compounds such as L-N acetylcysteine (L-NAC) and D-methionine (D-MET) have shown promising results as potent otoprotectors against cisplatin-induced ototoxicity in animal studies.
Material and Method
In this study, we investigated a method to increase the efficacy of L-NAC and D-MET without increasing dose. Sprague Dawley rats were noise conditioned for 15 minutes immediately after intraperitoneal injection of 275 mg/kg L-NAC or 300 mg/kg D-MET. Another set of rats received 275 mg/kg L-NAC or 300 mg/kg D-MET alone, and 1 group underwent noise conditioning alone. All 5 groups were administered 14 mg/kg cisplatin intravenously 1 hour after otoprotector injection or 45 minutes after noise conditioning.
Results
Otoprotectors and noise conditioning, alone or in combination, were analyzed for their ability to reduce cisplatin-induced ototoxicity. The results indicated that the combination of 275 mg/kg L-NAC and noise conditioning afforded more otoprotection than 275 mg/kg L-NAC alone. In the case of D-MET, 300 mg/kg plus noise conditioning was little better than 300 mg/kg D-MET alone. In addition, we found that noise conditioning alone showed otoprotection against cisplatin-induced ototoxicity.
Conclusions
The ability of noise conditioning to protect against cisplatin-induced ototoxicity requires additional study.
Keywords: Pilot Projects, Noise - adverse effects, Hearing Loss - chemically induced, Cisplatin - pharmacology, Weight Loss - drug effects
Editorial
01 October 2024 : Editorial
Editorial: Potentials and Pitfalls in Targeting Glucagon-Like Peptide-1 (GLP-1) in the Management of Increasing Levels of ObesityDOI: 10.12659/MSM.946675
Med Sci Monit 2024; 30:e946675
In Press
Clinical Research
Cold Pressor Test Induces Significant Changes in Internal Jugular Vein Flow Dynamics in Healthy Young AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.946055
Clinical Research
Serum Albumin-to-Creatinine Ratio Predicts One-Year Mortality in Elderly Patients with Non-ST-Elevation Acu...Med Sci Monit In Press; DOI: 10.12659/MSM.945516
Clinical Research
Uric Acid to Albumin Ratio as a Predictive Marker for Intracoronary Thrombus Severity in ST-Segment Elevati...Med Sci Monit In Press; DOI: 10.12659/MSM.945832
Database Analysis
Systematic Review of Arthroscopic Bankart Repair Outcomes for Anterior Shoulder InstabilityMed Sci Monit In Press; DOI: 10.12659/MSM.945942
Most Viewed Current Articles
17 Jan 2024 : Review article 6,057,955
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research 1,853,190
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 694,082
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
07 Jan 2022 : Meta-Analysis 258,356
Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...DOI :10.12659/MSM.935074
Med Sci Monit 2022; 28:e935074